Home > Drug Search >
  • company_query: AnaMar
  •   > 
Drug Filter
Category:
chemistry (24) biology (5)
Status:
Approved (2) NDA Filing (1) Phase Ⅲ (1) Phase Ⅱ (14) Phase Ⅰ (11)
Clinical Stage:
Pending (5) Active (18) Discontinued (4)
Bio-Type:
Cell therapy (1) Recombinant cytokines (1) Whole antibody (1) ADC (1) Fusion protein (1)
Indication:
Acne (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Anemia (1) Atopic dermatitis (1) Crohn's disease (1) Cutaneous T cell lymphoma (CTCL) (1) Duchenne muscular dystrophy (DMD) (1) Transplant rejection (1) Gastric cancer (1) HCV infection (1) HIV infection (2) Influenza virus infection (1) Lymphoma (1) Malignancies (1) Melanoma (1) Non small cell lung cancer (NSCLC) (3) Periodontitis (1) Rheumatoid arthritis (RA) (1) Smoking cessation (1) Solid tumours (5) Ulcerative colitis (1) Head and neck cancer (1) Colorectal cancer (2) Colon cancer (1) Age-related macular degeneration (AMD) (1) Acute ischemic stroke (AIS) (1) Glioblastoma (1) Glioma (2) Gingival diseases (1) Respiratory syncytial virus infection (1) Cocaine abuse (1) Stargardt’s disease (1) Liver cancer (1) Musculoskeletal pain (1) Gastrointestinal cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top